Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Tresadern

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptorRadovan Spurny, Sarah Debaveye, Ana Farinha, et al.
Scientific Data|July 7, 2024
Dataset for quantum-mechanical exploration of conformers and solvent effects in large drug-like moleculesLeonardo Medrano Sandonas, Dries Van Rompaey, Alessio Fallani, et al.
Journal of Chemical Information and Modeling|August 2, 2024
ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug DiscoveryAlbert Bou, Morgan Thomas, Sebastian Dittert, et al.
Structure (London, England : 1993)|September 10, 2014
The prokaryote ligand-gated ion channel ELIC captured in a pore blocker-bound conformation by the Alzheimer's disease drug memantineChris Ulens, Radovan Spurny, Andrew J Thompson, et al.
Journal of Chemical Theory and Computation|July 24, 2023
Broadening the Scope of Binding Free Energy Calculations Using a Separated Topologies ApproachHannah M Baumann, Eric Dybeck, Christopher L McClendon, et al.
British Journal of Pharmacology|November 22, 2015
Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222Maarten L J Doornbos, Laura Pérez-Benito, Gary Tresadern, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target EngagementPeter Buijnsters, Meri De Angelis, Xavier Langlois, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2011
Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitorsGary Tresadern, Francisca Delgado, Oscar Delgado, et al.
Journal of Chemical Information and Modeling|October 16, 2025
MolAgent: Biomolecular Property Estimation in the Agentic EraJose Carlos Gómez-Tamayo, Joris Tavernier, Roy Aerts, et al.
Journal of Chemical Theory and Computation|October 30, 2023
Alchemical Free Energy Calculations on Membrane-Associated ProteinsMichail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptorRadovan Spurny, Sarah Debaveye, Ana Farinha, et al.
Scientific Data|July 7, 2024
Dataset for quantum-mechanical exploration of conformers and solvent effects in large drug-like moleculesLeonardo Medrano Sandonas, Dries Van Rompaey, Alessio Fallani, et al.
Journal of Chemical Information and Modeling|August 2, 2024
ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug DiscoveryAlbert Bou, Morgan Thomas, Sebastian Dittert, et al.
Structure (London, England : 1993)|September 10, 2014
The prokaryote ligand-gated ion channel ELIC captured in a pore blocker-bound conformation by the Alzheimer's disease drug memantineChris Ulens, Radovan Spurny, Andrew J Thompson, et al.
Journal of Chemical Theory and Computation|July 24, 2023
Broadening the Scope of Binding Free Energy Calculations Using a Separated Topologies ApproachHannah M Baumann, Eric Dybeck, Christopher L McClendon, et al.
British Journal of Pharmacology|November 22, 2015
Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222Maarten L J Doornbos, Laura Pérez-Benito, Gary Tresadern, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target EngagementPeter Buijnsters, Meri De Angelis, Xavier Langlois, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2011
Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitorsGary Tresadern, Francisca Delgado, Oscar Delgado, et al.
Journal of Chemical Information and Modeling|October 16, 2025
MolAgent: Biomolecular Property Estimation in the Agentic EraJose Carlos Gómez-Tamayo, Joris Tavernier, Roy Aerts, et al.
Journal of Chemical Theory and Computation|October 30, 2023
Alchemical Free Energy Calculations on Membrane-Associated ProteinsMichail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.
Pageof 10